A Common CD36 Variant and the Genetic Landscape of Dilated Cardiomyopathy in Individuals of African Ancestry

This multicohort study reveals that a common, ancestry-specific CD36 nonsense variant contributes more significantly to the burden of dilated cardiomyopathy in individuals of African ancestry than established genetic causes, including TTN truncating variants, thereby reshaping the understanding of the disease's genetic architecture in this population.

The Gist

Imagine the human heart as a high-performance engine that needs two things to keep running smoothly: a strong structural frame (the skeleton) and a steady supply of fuel (energy). For a long time, scientists studying heart failure believed that when this engine broke down, it was usually because the structural frame was defective. They found broken "beams" in the heart's skeleton, specifically in a gene called TTN, and assumed this was the main culprit for most cases of heart failure, especially a type called Dilated Cardiomyopathy (DCM).

However, this study suggests that for people of African ancestry, the story is different. It's not just about the broken frame; sometimes, the engine is failing because it's running out of fuel.

Here is the breakdown of what the researchers found, using simple analogies:

1. The Missing Piece of the Puzzle

Scientists have been trying to solve the mystery of why heart failure is more common and often more severe in people of African ancestry compared to people of European ancestry. They had a list of "suspects" (genes known to cause heart failure), but these suspects only explained a small part of the problem in African populations. It was like trying to solve a crime with only half the evidence.

2. The New Suspect: The "Fuel Pump"

The researchers discovered a specific genetic variant (a typo in the DNA code) in a gene called CD36.

• What CD36 does: Think of CD36 as a fuel pump that helps the heart muscle grab fatty acids (its main fuel source) from the blood.
• The Problem: In this specific variant, the fuel pump is broken. It's a "nonsense" mutation, meaning the instructions stop too early, and the pump never gets built.
• Who has it: This broken fuel pump is very common in people of African ancestry (about 16% of people carry one copy, and about 1% carry two broken copies). It is almost non-existent in people of European ancestry.

3. The Big Reveal: Fuel vs. Frame

The study compared the impact of this broken "fuel pump" (CD36) against the famous "broken frame" genes (like TTN).

• The Surprise: In people of African ancestry, having two broken copies of the CD36 gene (a broken fuel pump) was a bigger cause of heart failure than having the broken TTN frame.
• The Numbers:
  • If you have two broken CD36 copies, your risk of heart failure jumps nearly 5 times.
  • If you look at all the people with heart failure in this group, the broken CD36 gene explains 9% of the cases.
  • The famous TTN gene only explains about 3.6% of the cases in this same group.

4. The "Half-Broken" Pump Matters Too

Even people with just one broken CD36 copy (heterozygotes) had a higher risk of heart failure (about 1.4 times higher). Because so many people carry this single copy, it adds up to a huge number of cases in the population. It's like having a slightly clogged fuel line; it doesn't stop the car immediately, but over time, it causes the engine to struggle much more often than a rare, broken beam would.

5. Why This Changes the Map

For years, the "map" of heart failure genetics was drawn mostly using data from people of European ancestry. On that map, the "broken frame" (TTN) was the biggest landmark.

• The New Map: This study redraws the map for people of African ancestry. It shows that the "broken fuel pump" (CD36) is actually the most significant single genetic landmark in this population.
• The Lesson: If you only look at the European map, you miss the biggest danger zone for African populations. This proves that to understand heart disease fully, we need to look at diverse groups, not just one.

Summary

This paper tells us that for people of African ancestry, a specific genetic glitch that breaks the heart's fuel delivery system is a major, previously overlooked cause of heart failure. In fact, it is a bigger contributor to the disease in this group than the most famous genetic causes known so far. It highlights that the heart's energy supply is just as critical as its structural strength, and that different populations may have different "weak links" in their heart's design.

Technical Summary

Technical Summary: A Common CD36 Variant and the Genetic Landscape of Dilated Cardiomyopathy in Individuals of African Ancestry

Problem Statement
Dilated cardiomyopathy (DCM) disproportionately affects individuals of African genetic ancestry (AFR), who experience higher incidence, earlier onset, and more severe outcomes compared to those of European ancestry (EUR). While pathogenic variants in established monogenic DCM genes (such as TTN) explain a significant portion of DCM cases in EUR populations, sequencing studies in AFR populations have identified fewer such variants, suggesting a "missing heritability" gap. Previous genome-wide association studies identified a common, AFR-specific nonsense variant in the CD36 gene (Y325*, rs3211938) associated with DCM, but its relative contribution to the overall genetic architecture of DCM compared to established monogenic causes remained unquantified.

Methodology
This multicohort genetic association study analyzed data from four distinct datasets: the All of Us Research Program (AoU), the VA Million Veteran Program (MVP), the Penn Medicine Biobank (PMBB), and the clinically adjudicated DCM Precision Medicine Study (DCM-PM). The study included 82,623 individuals of AFR ancestry and 216,440 individuals of EUR ancestry.

The primary genetic exposures evaluated were:

1. CD36 Y325:* A nonsense variant (rs3211938), analyzed as 0, 1, or 2 copies of the risk allele.
2. TTN Truncating Variants (TTNtv): Rare, premature truncating variants in cardiac-expressed exons.
3. Pathogenic/Likely Pathogenic (P/LP) Variants: In 11 other high-confidence ClinGen-curated DCM genes (BAG3, DES, FLNC, LMNA, MYH7, PLN, RBM20, SCN5A, TNNC1, TNNT2, DSP).

DCM cases were defined via ICD-10 codes (excluding ischemic causes) in biobanks and clinically adjudicated in the DCM-PM cohort. Statistical associations were assessed using Firth penalized logistic regression, adjusted for age, sex, genetic ancestry principal components, and cohort-specific covariates. Effect estimates were combined via fixed-effect meta-analysis. The study calculated odds ratios (OR), prevalence of carriers among cases, and population-attributable fraction (PAF) to quantify the burden of each genetic factor.

Key Results

• Risk Magnitude: In AFR participants, CD36 Y325* homozygotes (G/G) exhibited a 4.8-fold increased odds of DCM (95% CI, 3.1–7.3), while heterozygotes showed a 1.4-fold increased odds (95% CI, 1.2–1.7). TTNtv carriers also showed elevated risk (OR, 8.46; 95% CI, 5.3–12.3).
• Prevalence Among Cases: Among AFR DCM cases, CD36 Y325* homozygotes accounted for 2.5% of cases. This prevalence was second only to TTNtv (4.3%) and exceeded the combined prevalence of P/LP variants in the other 11 high-confidence DCM genes (1.5%).
• Population Attributable Fraction (PAF): When considering all carriers (heterozygotes and homozygotes), the PAF for CD36 Y325* in AFR populations was 9.0%. This surpassed the PAF for TTNtv (3.6%) and all other established high-confidence DCM genes combined.
• Genetic Architecture: Including CD36 Y325* homozygotes increased the proportion of AFR DCM cases with an identifiable monogenic contributor from 14.3% to 35.8%. Within this expanded group, 31.4% were CD36 homozygotes, shifting the mechanistic understanding from sarcomere-centric pathways to myocardial energetics.
• Ancestry Specificity: The CD36 Y325* variant is nearly absent in EUR populations (MAF <0.001%) but present in approximately 16% of AFR individuals, whereas TTNtv frequencies were similar across ancestries (~0.5%).

Significance and Claims
The paper claims that the CD36 Y325* variant is a major, ancestry-specific contributor to the genetic burden of DCM in individuals of African ancestry, exceeding the population-level impact of TTN truncating variants and other established monogenic causes. The findings suggest that the prevailing view of DCM genetic architecture, largely derived from EUR cohorts where TTN is the dominant factor, requires revision for AFR populations.

The authors assert that this discovery:

1. Reshapes Genetic Architecture: It identifies a single variant that accounts for a larger share of DCM burden in AFR populations than any other single gene or variant class previously recognized.
2. Shifts Biological Paradigms: Unlike most DCM genes which affect sarcomere structure, CD36 loss-of-function impairs myocardial contractility through the disruption of fatty acid transport and cardiac fuel utilization, highlighting energetic mechanisms as a critical component of DCM pathogenesis in this population.
3. Underscores Diversity: The study emphasizes that excluding ancestral diversity from genomic research leads to an incomplete understanding of disease etiology and that ancestry-specific discoveries are essential for equitable genetic evaluation and precision medicine frameworks.

The authors conclude that clinical genetic evaluation for AFR patients with DCM should consider CD36 Y325* genotyping, particularly to identify homozygous carriers, and that future precision therapies must incorporate these energetic mechanisms.